Literature DB >> 33611457

Physical activity/inactivity and COVID-19.

Antonio Crisafulli1, Pasquale Pagliaro2.   

Abstract

Entities:  

Year:  2020        PMID: 33611457      PMCID: PMC7928968          DOI: 10.1177/2047487320927597

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


× No keyword cloud information.
The pandemic coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has spread globally impacting health and economy on an unprecedented scale. Hundreds of thousands of patients are dying worldwide. Many are adult men with three or more pre-existent comorbidities, especially metabolic syndrome (MS) and cardiovascular diseases (CVDs). Although COVID-19 is primarily a respiratory infection, patients with MS and CVDs experience disproportionately worse outcomes. Until an effective vaccine or a drug against SARS-CoV-2 become available, the only strategy appears to be a combination of social isolation, contact tracing and rapid diagnosis. In an attempt to hinder the spread of COVID-19, governments are taking measures that tighten the quarantine, requiring all citizens to stay home as much as possible. These measures have deleterious consequences on everyone’s life. Among others, there is also a serious concern related to the deleterious effects of physical inactivity. All sports events have been suspended or cancelled. As human droplets are the main vehicle of contagion, during physical activities, and especially in group activities, hyperventilation increases the risk of infection, despite maintaining the suggested social distance of 1.5 m. It has been reported that, under various combinations of environmental and patient conditions, droplets of all sizes can travel up to 7–8 m. However, to the best of our knowledge, there is no rigorous study investigating droplet spread during hard effort such as running or cycling. In addition, sports-related injury should be limited as hospitals are already engaged with the massive number of cases of COVID-19. Thus, on the one hand the limitation of physical activities serves to counteract the COVID-19 outbreak, on the other hand this certainly entails problems related to the abrupt interruption and/or severe limitation of physical activities. The SARS-CoV-2 virus is linked to the renin–angiotensin system (RAS), which plays a central role in blood pressure regulation and in the body’s response to exercise. However, regular physical activity affects RAS functioning. In this commentary, we highlight this RAS–COVID-19 relationship and analyse the possible consequences of a severe limitation of physical activity during this pandemic (see Figure 1).
Figure 1.

Simplified diagram showing the connection between physical training and the renin–angiotensin system. Top insert: schematic model of the angiotensin-converting enzyme (ACE) and ACE2 interactions at the cell membrane level. These two enzymes are aminopeptidases that remove amino acids from precursors to obtain ligands (i.e. angiotensin ANG II and ANG 1-7), which will bind to receptors (ANG II receptor (AT) ANG 1-7 receptor (MAS), respectively) obtaining specific effects on the cardiovascular system. Physical training can affect ACE2 expression, while coronavirus can interfere with ACE2 activity. Also apelin and its G-protein coupled receptor (APJ) are linked to ACE2 and apelin overexpression has been linked to physical training.

Simplified diagram showing the connection between physical training and the renin–angiotensin system. Top insert: schematic model of the angiotensin-converting enzyme (ACE) and ACE2 interactions at the cell membrane level. These two enzymes are aminopeptidases that remove amino acids from precursors to obtain ligands (i.e. angiotensin ANG II and ANG 1-7), which will bind to receptors (ANG II receptor (AT) ANG 1-7 receptor (MAS), respectively) obtaining specific effects on the cardiovascular system. Physical training can affect ACE2 expression, while coronavirus can interfere with ACE2 activity. Also apelin and its G-protein coupled receptor (APJ) are linked to ACE2 and apelin overexpression has been linked to physical training. The classic angiotensin-converting enzyme (ACE) and ACE2 are two important enzymes of RAS. These enzymes and their products act in balancing each other: while ACE converts angiotensin-I to angiotensin-II (Ang-II), a potent vasoconstrictor, ACE2 leads to the formation of angiotensin 1-7 (Ang-1-7), a potent vasodilator. Ang-II binding to type 1 receptors (AT1) also induces sympathetic activation, reactive oxygen species (ROS) generation and endothelial dysfunction, as well as the induction of inflammatory, thrombotic, proliferative and fibrotic processes. On the contrary, Ang-1-7 binding to the Mas receptor (MasR) mediates anti-inflammatory, anti-proliferative and anti-oxidative effects. These different effects explain their opposite role in hypertension, MS, diabetes and CVDs. Therefore, ACE, ACE2 and their products have multiple and opposite effects in the RAS and in exercise training (see Figure 1). In order to enter target cells, SARS-CoV-2 uses transmembrane protease serine 2 (TMPRSS2) to split the virus spike protein and uses ACE2 as a cellular receptor. The maximum expression of ACE2 is observed in the organs targeted by the virus, namely the lungs, kidneys, heart and their endothelium. Therefore, ACE2 could play a role in the mechanism of acute myocardial injury induced by COVID-19., The ACE2/Ang-1-7/MasR arm of the RAS exerts beneficial effects in skeletal muscle and is needed to develop muscle hypertrophy during exercise training. Actually, ACE2 knockout mice do not show muscle hypertrophy after exercise training. Moreover, Ang-1-7 has anti-atrophic effects and improves insulin sensitivity in skeletal muscles. However, Ang-1-7 acting on MasR stimulates the phosphorylation/activation of Akt, an enzyme involved in insulin signalling, and in cell survival and growth., Although in several CVDs there is an upregulation of the ACE/Ang-II/AT1 arm of the RAS, exercise training shifts the balance of the RAS towards the protective arm (ACE2/Ang1-7/MasR). ACE2 knockout mice spontaneously perform low exercise volumes and do not benefit in body composition. Studies suggest that a high exercise volume is necessary to shift the balance of RAS towards the ACE2/Ang-1-7/Mas receptor axis., Studies on the ACE genotype and RAS polymorphism demonstrated that RAS might also modulate the effect of exercise training in humans. COVID-19 infection, affecting lung and cardiovascular function, impairs exercise capacity. In addition, the inevitable quarantine and restrictions imposed by governments during the outbreak could exacerbate the negative consequences of the infection itself. A sedentary lifestyle is the potential leading cause of CVDs, which are the major cause of death in the world. Due to mandatory homestay, the COVID-19 outbreak will probably worsen this situation because of the reduction in both habitual and recreational physical activities. The World Health Organization suggests that ‘Adults aged 18–64 should do at least 150 minutes of moderate-intensity aerobic physical activity or do at least 75 minutes of vigorous-intensity aerobic physical activity throughout the week or an equivalent combination of moderate and vigorous-intensity activity.’ (https://www.who.int/dietphysicalactivity/factsheet_adults/en/). Clearly it is very difficult to comply with these WHO recommendations for citizens in lockdown areas. The notion that physical activity is cardioprotective and that being sedentary is a risk factor for MS and CVDs is supported by the great bulk of evidence. Regular physical activity has a significant impact in reducing the total and cardiac mortality rate. Moreover, exercise is a useful tool for cardiovascular rehabilitation. Conversely, inactive individuals have about a two-fold higher relative risk of coronary artery disease in comparison with physically active people. To support further the concept that regular physical activity is a good practice to stay healthy, there is evidence that physical capacity is a good predictor of the increased risk of death from any cause in healthy individuals as well as in patients with CVDs. Regular physical activity reduces several risk factors related to CVDs. Besides the shift of the RAS balance towards the protective arm (ACE2/Ang1-7/MasR), improvement in insulin sensitivity, enhancement in endothelial functions, structural adaptations in the coronary tree and a reduction in autonomic activity and in vascular resistance and blood pressure have all been reported. Considering the positive effects of physical activity on the general and cardiovascular health state, it is advisable that the population keeps exercising at home. Good tools are treadmills, stationary bikes and rowing machines. The use of fitness balls, elastic bands and weights is advisable. Exercise driven by video and online-guided protocols may be very useful. Even going up and down the stairs can help. Local authorities should consider allowing, whenever possible, some outdoor activities with a sufficient interpersonal distance (more than 1.5 m). In this regard, a study investigating the distance reached by droplets during efforts is warranted. While there is no doubt that an active lifestyle confers protection against CVDs, some potential controversy regarding ACE2 expression deserves much attention, especially considering that it is necessary for the beneficial effects of exercise, but it provides the pathway for the SARS-CoV-2 virus to enter the body. Although never proved in humans, an overexpression of ACE2 has been demonstrated in animal models of high volume exercise training. Moreover, once the body is infected, the SARS-CoV-2 virus has the capacity to deplete ACE2., The potential overexpression of ACE2 in highly trained athletes may lead us to hypothesise that, despite their good health, they are more sensitive to SARS-CoV-2 invasion and COVID-19 consequences. Thus, it can be speculated that they may be more sensitive to RAS homeostasis perturbation by COVID-19. This is somehow similar to the hypothesised deleterious effects of ACE inhibitors and AT1 blockers. These hypotheses/speculations deserve attention and require appropriate investigations, but there is no evidence to recommend stopping exercise or stopping ACE inhibitors. Whereas there are no data on the potential risks related to COVID-19 in people with high-level training, there is evidence that MS worsens COVID-19, while exercise is beneficial in the general population. Thus, exercise benefits may outweigh the hypothesised risks. One challenging point is how to distance people during exercise. There is an urgent need for rigorous investigations on droplet spread during hard efforts. In the meantime, as droplets can probably travel for several metres during hyperventilation, the use of masks during exercise appears to be mandatory. It is clearly a challenge for governments to decide when the benefits of a reduction of cardiovascular risks with exercise surpass the need for strict measures for containment of the epidemic. In our opinion people should, in any case, keep exercising at home whenever possible. Jogging alone and wearing a mask could be a step forward when epidemic conditions improve (i.e. the prevalence and increase in new cases are appreciably reduced). We are only at the beginning of the battle against this terrible pandemic, so let’s run!
  12 in total

1.  Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise.

Authors:  Daisy Motta-Santos; Robson Augusto Souza Dos Santos; Marilene Oliveira; Fatimunnisa Qadri; Marko Poglitsch; Valentina Mosienko; Lenice Kappes Becker; Maria Jose Campagnole-Santos; Joseph M Penninger; Natalia Alenina; Michael Bader
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

2.  Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.

Authors:  Marina C Muñoz; Jorge F Giani; Fernando P Dominici
Journal:  Regul Pept       Date:  2010-02-25

3.  Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19.

Authors:  Lydia Bourouiba
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

Review 4.  Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?

Authors:  Nicolle Kränkel; Martin Bahls; Emeline M Van Craenenbroeck; Volker Adams; Luis Serratosa; Erik Ekker Solberg; Dominique Hansen; Marcus Dörr; Hareld Kemps
Journal:  Eur J Prev Cardiol       Date:  2018-10-15       Impact factor: 7.804

Review 5.  Rethinking the renin-angiotensin system and its role in cardiovascular regulation.

Authors:  Pasquale Pagliaro; Claudia Penna
Journal:  Cardiovasc Drugs Ther       Date:  2005-01       Impact factor: 3.727

6.  Genetic polymorphisms of the renin-angiotensin system and obesity-related metabolic changes in response to low-energy diets in obese women.

Authors:  Taku Hamada; Kazuhiko Kotani; Narumi Nagai; Kokoro Tsuzaki; Yoshiko Sano; Yukiyo Matsuoka; Mami Fujibayashi; Natsuki Kiyohara; Seitaro Tanaka; Makiko Yoshimura; Kahori Egawa; Yoshinori Kitagawa; Yoshinobu Kiso; Toshio Moritani; Naoki Sakane
Journal:  Nutrition       Date:  2010-04-03       Impact factor: 4.008

7.  The Science Underlying COVID-19: Implications for the Cardiovascular System.

Authors:  Peter P Liu; Alice Blet; David Smyth; Hongliang Li
Journal:  Circulation       Date:  2020-04-15       Impact factor: 29.690

8.  Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC).

Authors:  Hareld Kemps; Nicolle Kränkel; Marcus Dörr; Trine Moholdt; Matthias Wilhelm; Francesco Paneni; Luis Serratosa; Erik Ekker Solberg; Dominique Hansen; Martin Halle; Marco Guazzi
Journal:  Eur J Prev Cardiol       Date:  2019-01-14       Impact factor: 7.804

Review 9.  Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning.

Authors:  Antonio Crisafulli; Pasquale Pagliaro; Silvana Roberto; Lucia Cugusi; Giuseppe Mercuro; Antigone Lazou; Christophe Beauloye; Luc Bertrand; Derek J Hausenloy; Manuela Aragno; Claudia Penna
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

10.  Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.

Authors:  Gian Paolo Rossi; Viola Sanga; Matthias Barton
Journal:  Elife       Date:  2020-04-06       Impact factor: 8.140

View more
  14 in total

1.  Health promoting behaviour of medical versus non-medical students during COVID-19 pandemic: results from the COLA cross-sectional study.

Authors:  Stefan Brunner; Julius Steffen; Jenny Schlichtiger; Bruno C Huber
Journal:  J Transl Med       Date:  2021-06-04       Impact factor: 5.531

2.  Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times.

Authors:  Olívia Moraes Ruberti; Guilherme Defante Telles; Bruno Rodrigues
Journal:  Curr Cardiol Rev       Date:  2021

3.  Effects of Regular Physical Activity on the Immune System, Vaccination and Risk of Community-Acquired Infectious Disease in the General Population: Systematic Review and Meta-Analysis.

Authors:  Sebastien F M Chastin; Ukachukwu Abaraogu; Jan G Bourgois; Philippa M Dall; Jennifer Darnborough; Elaine Duncan; Jasmien Dumortier; David Jiménez Pavón; Joanna McParland; Nicola J Roberts; Mark Hamer
Journal:  Sports Med       Date:  2021-04-20       Impact factor: 11.136

4.  Lessons from COVID-19 for managing transboundary climate risks and building resilience.

Authors:  Andrew K Ringsmuth; Ilona M Otto; Bart van den Hurk; Glada Lahn; Christopher P O Reyer; Timothy R Carter; Piotr Magnuszewski; Irene Monasterolo; Jeroen C J H Aerts; Magnus Benzie; Emanuele Campiglio; Stefan Fronzek; Franziska Gaupp; Lukasz Jarzabek; Richard J T Klein; Hanne Knaepen; Reinhard Mechler; Jaroslav Mysiak; Jana Sillmann; Dana Stuparu; Chris West
Journal:  Clim Risk Manag       Date:  2022-01-11

5.  Associations between screen time, physical activity, and depressive symptoms during the 2019 coronavirus disease (COVID-19) outbreak among Chinese college students.

Authors:  Yi Zhang; Xiaoyan Wu; Shuman Tao; Shiyue Li; Le Ma; Yizhen Yu; Guilong Sun; Tingting Li; Fangbiao Tao
Journal:  Environ Health Prev Med       Date:  2021-11-02       Impact factor: 4.395

6.  Outpatient Cardiac Rehabilitation Closure and Home-Based Exercise Training During the First COVID-19 Lockdown in Austria: A Mixed-Methods Study.

Authors:  Stefan Tino Kulnik; Mahdi Sareban; Isabel Höppchen; Silke Droese; Andreas Egger; Johanna Gutenberg; Barbara Mayr; Bernhard Reich; Daniela Wurhofer; Josef Niebauer
Journal:  Front Psychol       Date:  2022-02-15

7.  Physical Activity as a Predictor of the Level of Stress and Quality of Sleep during COVID-19 Lockdown.

Authors:  Anna Lipert; Remigiusz Kozłowski; Dariusz Timler; Michał Marczak; Kamila Musiał; Paweł Rasmus; Karolina Kamecka; Anna Jegier
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 4.614

8.  Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis.

Authors:  Antonio Cannata; Samuel A Watson; Allen Daniel; Mauro Giacca; Ajay M Shah; Theresa A McDonagh; Paul A Scott; Daniel I Bromage
Journal:  Eur J Prev Cardiol       Date:  2022-05-27       Impact factor: 8.526

Review 9.  Sex-related differences in COVID-19 lethality.

Authors:  Claudia Penna; Valentina Mercurio; Carlo G Tocchetti; Pasquale Pagliaro
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 9.473

10.  Determinants of physical activity maintenance during the Covid-19 pandemic: a focus on fitness apps.

Authors:  Yanxiang Yang; Joerg Koenigstorfer
Journal:  Transl Behav Med       Date:  2020-10-08       Impact factor: 3.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.